T1	Participants 107 137	severely neutropenic patients.
T2	Participants 276 306	fever in neutropenic patients.
T3	Participants 336 392	patients who experienced a total of 247 febrile episodes
T4	Participants 848 879	All 247 episodes were evaluable
T5	Participants 1820 1849	febrile neutropenic patients.
